Phospholipase A2 is involved in the mechanism of activation of neutrophils by polychlorinated biphenyls

Environ Health Perspect. 1996 Jan;104(1):52-8. doi: 10.1289/ehp.9610452.

Abstract

Aroclor 1242, a mixture of polychlorinated biphenyls (PCBs), activates neutrophils to produce superoxide anion (O2-) by a mechanism that involves phospholipase C-dependent hydrolysis of membrane phosphoinositides; however, subsequent signal transduction mechanisms are unknown. We undertook this study to determine whether phospholipase A2-dependent release of arachidonic acid is involved in PCB-induced O2- production. We measured O2- production in vitro in glycogen-elicited, rat neutrophils in the presence and absence of the inhibitors of phospholipase A2: quinacrine, 4-bromophenacyl bromide (BPB), and manoalide. All three agents significantly decreased the amount of O2- detected during stimulation of neutrophils with Aroclor 1242. Similar inhibition occurred when neutrophils were activated with the classical stimuli, formyl-methionyl-leucyl-phenylalanine (fMLP) or phorbol myristate acetate. The effects of BPB and manoalide were not a result of cytotoxicity or other nonspecific effects, although data suggest that quinacrine is an O2- scavenger. Significant release of 3H-arachidonic acid preceded O2- production in neutrophils stimulated with Aroclor 1242 or fMLP. Manoalide, at a concentration that abolished O2- production, also inhibited the release of 3H-arachidonate. Aspirin, zileuton, or WEB 2086 did not affect Aroclor 1242-induced O2- production, suggesting that eicosanoids and platelet-activating factor are not needed for neutrophil activation by PCBs. Activation of phospholipase A2 and O2- production do not appear to involve the Ah receptor because a congener with low affinity, but not one with high affinity for this receptor, stimulated the release of arachidonic acid and O2-. These data suggest that Aroclor 1242 stimulates neutrophils to produce O2- by a mechanism that involves phospholipase A2-dependent release of arachidonic acid.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Arachidonic Acid / metabolism*
  • Aroclors / pharmacology
  • Aspirin / pharmacology
  • Cyclooxygenase Inhibitors / pharmacology
  • Hydroxyurea / analogs & derivatives
  • Hydroxyurea / pharmacology
  • In Vitro Techniques
  • Lipoxygenase Inhibitors / pharmacology
  • Male
  • N-Formylmethionine Leucyl-Phenylalanine / pharmacology
  • Neutrophil Activation
  • Neutrophils / drug effects*
  • Neutrophils / metabolism
  • Phospholipases A / antagonists & inhibitors
  • Phospholipases A / metabolism*
  • Phospholipases A2
  • Polychlorinated Biphenyls / pharmacology
  • Polychlorinated Biphenyls / toxicity*
  • Quinacrine / pharmacology
  • Rats
  • Superoxides / metabolism*
  • Terpenes / pharmacology
  • Tetradecanoylphorbol Acetate / pharmacology

Substances

  • Aroclors
  • Cyclooxygenase Inhibitors
  • Lipoxygenase Inhibitors
  • Terpenes
  • Superoxides
  • Arachidonic Acid
  • aroclor 1242
  • N-Formylmethionine Leucyl-Phenylalanine
  • Polychlorinated Biphenyls
  • manoalide
  • Phospholipases A
  • Phospholipases A2
  • Quinacrine
  • Tetradecanoylphorbol Acetate
  • Aspirin
  • zileuton
  • Hydroxyurea